Verastem Inc VSTM:NASDAQ

Last Price$1.27NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change+0.06(4.96%)
Bid (Size)$1.18 (263)
Ask (Size)$1.27 (79)
Day Low / High$1.22 - 1.27
Volume4.8 M
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Verastem Inc ( NASDAQ )

Price: $1.27
Change: +0.06 (4.96%)
Volume: 4.8 M
4:00PM ET 8/12/2022
 
 

Voyager Therapeutics Inc ( NASDAQ )

Price: $6.07
Change: -0.41 (6.33%)
Volume: 617.3 K
4:00PM ET 8/12/2022
 
 

Jounce Therapeutics Inc ( NASDAQ )

Price: $4.71
Change: +0.06 (1.29%)
Volume: 137.5 K
4:00PM ET 8/12/2022
 
 

Personalis Inc ( NASDAQ )

Price: $5.38
Change: +0.57 (11.85%)
Volume: 630.7 K
4:00PM ET 8/12/2022
 
 

Epizyme Inc ( NASDAQ )

Price: $1.47
Change: 0.00 (0.00%)
Volume: 22.3 M
4:00PM ET 8/11/2022
 

Read more news Recent News

-- Earnings Flash (VSTM) VERASTEM ONCOLOGY Posts Q2 Loss $-0.11
7:03AM ET 8/08/2022 MT Newswires

...

-- Earnings Flash (VSTM) VERASTEM ONCOLOGY Reports Q1 Loss $-0.08
4:41PM ET 5/09/2022 MT Newswires

...

-- Earnings Flash (VSTM) VERASTEM ONCOLOGY Posts Q1 Revenue $2.6M
4:41PM ET 5/09/2022 MT Newswires

...

Top Midday Gainers
1:46PM ET 4/14/2022 MT Newswires

Verastem (VSTM) was initiated at outperform with a speculative risk qualifier at RBC Capital Markets, which set the price target at $5 amid a bullish view...

View all Commentary and Analysis

Tracking Baker Brothers Portfolio - Q1 2022 Update
3:07AM ET 7/01/2022 Seeking Alpha

Verastem: Looking Increasingly Attractive
9:25AM ET 6/29/2022 Seeking Alpha

Verastem: Time To Take My Position Out Of Mothball
9:49AM ET 4/19/2022 Seeking Alpha

Tracking Baker Brothers Portfolio - Q4 2021 Update
10:10PM ET 3/30/2022 Seeking Alpha

Company Profile

Business DescriptionVerastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA. View company web site for more details
Address117 Kendrick Street
Needham, Massachusetts 02494
Phone+1.781.292.4200
Number of Employees169
Recent SEC Filing08/08/202210-Q
Chief Executive Officer & DirectorBrian M. Stuglik
President & Chief Operating OfficerDan Paterson
Chief Financial & Business OfficerRobert E. Gagnon
Chief Scientific OfficerJonathan Pachter

Company Highlights

Price Open$1.24
Previous Close$1.21
52 Week Range$1.00 - 3.58
Market Capitalization$238.5 M
Shares Outstanding187.8 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.43
Beta vs. S&P 500N/A
Revenue$26.7 M
Net Profit Margin-3,909,050.00%
Return on Equity-100.92%

Analyst Ratings as of 06/15/2022

Buy
5
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset